Repository Corticotropin Injection
Sponsors
University at Buffalo, Mallinckrodt, Arthritis Treatment Center, Maryland, The Cleveland Clinic, University of Alabama at Birmingham
Conditions
Amyotrophic Lateral SclerosisAnterior UveitisDiabetic NephropathyIdiopathic Membranous NephropathyKeratoconjunctivitis SiccaMultiple SclerosisOcular SarcoidosisPanuveitis
Phase 2
Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)
WithdrawnNCT00986960
Start: 2009-12-31End: 2010-12-31Updated: 2021-01-05
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
CompletedNCT01601236
Start: 2012-05-31End: 2016-03-31Updated: 2019-11-18
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
CompletedNCT01906658
Start: 2013-07-31End: 2014-12-31Updated: 2017-01-06
Phase 4
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
CompletedNCT01386554
Start: 2011-08-31End: 2017-05-05Updated: 2019-11-20
Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies.
CompletedNCT01966718
Start: 2013-10-31End: 2015-10-31Updated: 2016-08-18
ACTHAR Therapy for Central Nervous System Sarcoidosis
WithdrawnNCT02920710
Start: 2019-02-01End: 2020-11-02Updated: 2020-11-20
Repository Corticotropin Injection in Keratoconjunctivitis Sicca
WithdrawnNCT03398018
Start: 2018-11-01End: 2018-11-01Updated: 2018-12-14